Eurofins Genomics India Private Limited, a active private limited company, was established on 05 April 2004 in Bangalore, Karnataka, India. Engaging in biotechnology within the professional, scientific and technical sector, it holds CIN: U85195KA2004PTC033689. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹4.93 Cr.
Formerly known as Mwg-Biotech Private Limited. It upholds a compliant status. Employing 338 professional, Its leadership includes Sanjeev Irrappa Kamate (Managing Director), Pankaj Jaiminy (Additional Director). Past directors included Rouquet Nicolas Claude Jacques, Sanjeev Irrappa Kamate, Elpied Edward Aranha. It holds ₹2.70 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at #540/1,Ground Floor,Doddenakundi Industrial Area 2 Hoodi, Whitefield,, Bangalore, Karnataka, 560048.
U85195KA2004PTC033689
033689
05 April 2004
₹6.00 Cr
₹4.93 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Eurofins Genomics India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjeev Irrappa Kamate | Managing Director | 05 Nov 2019 | Current |
| Pankaj Jaiminy | Additional Director | 08 Sep 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Jan 2018 | Past |
| Pramod Abcsdd | Additional Director | 09 Jul 2020 | Past |
| Pramod Abcsdd | Director | 19 Jan 2009 | Past |
| Pramod Abcsdd | Additional Director | 25 Sep 2019 | Past |
| Pramod Abcsdd | Director | 27 Feb 2019 | Past |
| Pramod Abcsdd | Director | 25 Feb 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Eurofins Genomics India Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 5.73% decrease. The company also saw a substantial fall in profitability, with a 250.65% decrease in profit. The company's net worth Soared by an impressive increase of 37.51%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Eurofins Genomics India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,699,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 2022 | Axis Bank Limited | ₹2.70 M | Open |
Explore comprehensive loan charge details -
Eurofins Genomics India has a workforce of 338 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Eurofins Genomics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eurofins Genomics India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Eurofins Genomics India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Progress on Pankaj Jaiminy was appointed as a Additional Director was appointed as a Additional Director on 08 Sep 2025 & has been associated with this company since 2 months 24 days . was documented.
The activity Eurofins Genomics India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was completed.
A charge with Axis Bank Limited amounted to Rs. 0.27 Cr with Charge ID 100557656 was registered on 31 Mar 2022. was recorded as a recent event.
The activity Sanjeev Irrappa Kamate was appointed as a Managing Director was appointed as a Managing Director on 05 Nov 2019 & has been associated with this company since 6 years 26 days . was completed.
Eurofins Genomics India Private Limited was registered on 05 Apr 2004 with Roc Bangalore & aged 21 years 7 months as per MCA records. was recorded as a recent event.
The CIN of Eurofins Genomics India Private Limited is U85195KA2004PTC033689.
Eurofins Genomics India Private Limited is headquartered at #540/1,Ground Floor,Doddenakundi Industrial Area 2 Hoodi, Whitefield,, Bangalore, Karnataka, 560048.
Eurofins Genomics India Private Limited was incorporated on 05 April 2004.
The current directors of Eurofins Genomics India Private Limited are
The primary industry of Eurofins Genomics India Private Limited is Professional, Scientific And Technical.
Eurofins Genomics India Private Limited is unlisted.
The authorized capital of Eurofins Genomics India Private Limited is ₹6.00 Cr, and the paid-up capital is ₹4.93 Cr.
The compliance status of Eurofins Genomics India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX